Clinical Trial: Clinical Study to Evaluate the Efficacy and Safety of Mesenchymal Stromal Cells (Amimestrocel ) in Patients With Acute Kidney Injury

U.S., May 3 -- ClinicalTrials.gov registry received information related to the study (NCT06954740) titled 'Clinical Study to Evaluate the Efficacy and Safety of Mesenchymal Stromal Cells (Amimestrocel ) in Patients With Acute Kidney Injury' on April 24.

Brief Summary: This trial is to evaluate the efficacy and safety of Amimestrocel (human umbilical cord mesenchymal stromal cells) in the treatment of AKI patients.

Study Start Date: May 15

Study Type: INTERVENTIONAL

Condition: Acute Kidney Injury

Intervention: DRUG: Amimestrocel

Amimestrocel will be administered at a target dose of 1x10E6 MSCs/kg body weight on day 1, 4, 8, 15.

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Chinese PLA General Hospital

Information provided by (Re...